Integrated Research share price rises on record FY19 result

The Integrated Research Ltd (ASX: IRI) share price has jumped more than 5% in early trade after the software company reported a record full-year result

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Integrated Research Limited (ASX: IRI) share price has jumped in early trade after the software company reported a record full-year result prior to market open.

What did Integrated Research announce?

For the year ended 30 June 2019 (FY19), Integrated Research announced that it had passed key milestones in hitting $100 million in revenue and $20 million in profit for the first time.

The Aussie performance management software group increased net profit after tax (NPAT) by 14% on the prior corresponding period (pcp) to $21.9 million, at the top end of its July 2019 guidance range.

The strong profit result was made possible by a 19% increase in new licence sales throughout the year, which saw revenue surge 11% on pcp to $100.8 million.

The biggest contributor to revenue was the group's Unified Communications and Contact Centre segment, which comprised roughly half of all earnings despite a 7% decrease on pcp.

Payments revenue surged 92%, albeit off a low base, to $16 million for the year largely thanks to a combination of new and renewal business, while the company's Infrastructure segments increased by 28% to $26.3 million.

However, management is not resting on its laurels following the strong result, with gross spending on research and development maintained at 19% of revenue while Integrated Research's earnings before interest, tax, depreciation and amortisation (EBITDA) remains at 40%.

Positively for shareholders, Integrated Research's net profit after tax (NPAT) margin edged higher to 22% (versus 21% in pcp) as NPAT surged 12% higher for the year.

On the dividend side, Integrated Research directors declared a fully franked, interim dividend of 3.75 cents per share (cps), which takes the company's full-year dividend to 7.25 cps (versus 6.5 cps in pcp).

Foolish takeaway

All in all I think this morning's result was a positive one for Integrated Research and its shareholders, underscored by the strong profit numbers and margins.

Investors look like they tend to agree, with the Integrated Research share price trading more than 5% higher at one point in morning trade and currently trading 3.86% higher at time of writing. Overall, the shares have climbed nearly 60% higher since the start of the year.

Kenneth Hall has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Integrated Research Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Latin Resources, Newmont, Nick Scali, and ResMed shares are surging today

These ASX shares are ending the week strongly. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Let's also take a look at what the various ASX sectors were doing this Wednesday.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Argosy Minerals, Immutep, Pointsbet, and Regis Resources shares are racing higher

These shares are having a strong session on Wednesday. But why?

Read more »

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Smiling man working on his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to the races for ASX shares today, in a confident start to the week.

Read more »

rising gold share price represented by a green arrow on piles of gold block
Share Gainers

Here are the top 10 ASX 200 shares today

It was a horrible way to end the trading week today for ASX investors.

Read more »